GLS Pharma is a renowned Oncology PCD Pharma Franchise Company in India and the oncology-focused subsidiary of Aurobindo Pharma. Established in 2007, the company is dedicated to developing, manufacturing, and marketing high-quality oncology medicines that improve cancer treatment accessibility across India and international markets. Operating from its state-of-the-art WHO-GMP certified manufacturing facility in Hyderabad, GLS Pharma delivers world-class pharmaceutical solutions while maintaining the highest standards of quality, safety, and innovation.

The company manufactures a comprehensive oncology portfolio that includes liquid injectables, lyophilized injectables, oral solid dosage forms, supportive care medicines, and specialty oncology formulations used in the treatment of various cancers. Equipped with advanced isolator technology, automated robotic filling systems, and Class 100/Grade A aseptic processing environments, GLS Pharma ensures contamination-free production and consistent product quality. Its products are supplied to more than 30 countries through a strong international distribution network.

GLS Pharma also offers strategic business partnerships supported by technical expertise, dependable product availability, and a commitment to affordable oncology care. Backed by the global strength of Aurobindo Pharma, the company continues to invest in research, innovation, and manufacturing excellence, making it one of the most trusted Oncology PCD Pharma Franchise Companies for healthcare businesses seeking reliable cancer care solutions.